Guidant

BioTherapeutics

Home

About

Technology

Pipeline

Blogs

Guidant

BioTherapeutics

Insights and Reseach

Stay up to date with the latest research, clinical progress and scientific perspectives from the Guidant BioTherapeutics team.

All Categories

Clinical Progress

Scientific Perspectives

Research Updates

Scientific Perspectives

May 8, 2026

Albumin ADC Delivery: Can Albumin-Binding Strategies Solve the HER2 Tumor Penetration Problem?

Read article

Scientific Perspectives

May 20, 2026

Why Solid Tumors Remain Hard to Reach: The Case for Albumin-Based Navigated Delivery

Read article

Publications

SON-1010 (IL12-FHAB) Synergizes with Trabectedin in Advanced Soft-tissue Sarcoma

Apr 7, 2026

SON-1010 (IL12-FHAB) Synergizes with Trabectedin in Advanced Soft-tissue Sarcoma

Apr 7, 2026

Enhanced Efficacy of Immune Modulators with Albumin Binding Domains (ABD)

Presented at American Association of Cancer Research (AACR) Annual Meeting

Oct 13, 2017

Enhanced Efficacy of Immune Modulators with Albumin Binding Domains (ABD)

Presented at American Association of Cancer Research (AACR) Annual Meeting

Oct 13, 2017

A Novel Strategy to Produce High Level and High Purity of Bioactive IL15 Fusion Proteins from Mammalian Cells

Protein Expression and Purification 148 (2018) 30–39

Apr 13, 2018

A Novel Strategy to Produce High Level and High Purity of Bioactive IL15 Fusion Proteins from Mammalian Cells

Protein Expression and Purification 148 (2018) 30–39

Apr 13, 2018

An Innovative Human Platform for Targeted Delivery of Bispecific Interleukins to Tumors

Presented at the 2022 American Association of Cancer Research (AACR) Annual Meeting

Apr 13, 2022

An Innovative Human Platform for Targeted Delivery of Bispecific Interleukins to Tumors

Presented at the 2022 American Association of Cancer Research (AACR) Annual Meeting

Apr 13, 2022

Guidant

BioTherapeutics

© 2026 Guidant BioTherapeutics, Inc. All Rights Reserved.

Privacy Policy

Disclaimer